Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human defensins.

Josef Johann Schneider1, Angela Unholzer, Martin Schaller

  • 1Klinik und Poliklinik für Dermatologie und Allergologie, Ludwig-Maximilians-Universität München, Frauenlobstrasse 9-11, 80337 Munich, Germany. josefschneider@gmx.de

Journal of Molecular Medicine (Berlin, Germany)
|April 12, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The PET tracer [<sup>11</sup>C]MODAG-005 targets alpha-synuclein aggregates in the brain.

Science translational medicine·2026
Same author

Noninvasive in vivo imaging of NF-κB activation predicts immunotherapy response in solid tumors.

Npj imaging·2026
Same author

Polygenic, cell-envelope adaptations drive high-frequency daptomycin resistance in <i>Staphylococcus capitis</i> NRCS-A from neonatal sepsis and NEC.

Antimicrobial agents and chemotherapy·2026
Same author

The oncolytic vesicular stomatitis virus VSV-GP shows profound oncolytic activity in NUT-carcinoma cell lines.

Molecular therapy. Oncology·2026
Same author

Platelet Casein Kinase 2α is a pivotal player in arterial thrombotic occlusion and post-ischemic myocardial remodeling.

Cardiovascular research·2026
Same author

National Delphi consensus on laser and energy-based treatments for rosacea.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2025
Same journal

Non-transferrin-bound iron uptake by cardiomyocytes.

Journal of molecular medicine (Berlin, Germany)·2026
Same journal

Beyond the target: implications of Wnt pathway inhibitors on bone health.

Journal of molecular medicine (Berlin, Germany)·2026
Same journal

Proteomic analysis reveals divergent inflammatory mechanisms of COVID-associated Guillain-Barré syndrome.

Journal of molecular medicine (Berlin, Germany)·2026
Same journal

Integrative genetic and functional analysis of autosomal dominant hearing loss in 108 multigenerational families.

Journal of molecular medicine (Berlin, Germany)·2026
Same journal

Preclinical evaluation of cysteine protease-inhibitor aloxistatin (E64d) for heart failure therapy.

Journal of molecular medicine (Berlin, Germany)·2026
Same journal

Zinc-binding protein metallothionein 3 protects vascular smooth muscle cells from ferroptosis via blocking lysosomal degradation of GPX4.

Journal of molecular medicine (Berlin, Germany)·2026
See all related articles

Antimicrobial peptides, including human beta-defensins (HBDs), exhibit broad microbicidal activity. Novel HBD-3 and HBD-4 show potent activity against bacteria and fungi, with unique expression patterns.

Area of Science:

  • Innate Immunity
  • Antimicrobial Peptides
  • Molecular Biology

Background:

  • Antimicrobial peptides (AMPs) are crucial components of the innate immune system, exhibiting microbicidal activity against diverse pathogens.
  • Mammalian defensins, a class of AMPs, are categorized into alpha-, beta-, and theta-defensins based on structural and functional differences.
  • Human beta-defensins (HBDs) play a significant role in host defense, with recent discoveries of HBD-3 and HBD-4 expanding our understanding.

Purpose of the Study:

  • To provide an overview of human antimicrobial peptides.
  • To emphasize the antifungal properties of human antimicrobial peptides.
  • To highlight the characteristics and activities of newly discovered human beta-defensins, HBD-3 and HBD-4.

Main Methods:

Related Experiment Videos

  • Literature review and analysis of existing data on antimicrobial peptides.
  • Structural classification of eukaryotic antimicrobial peptides.
  • Comparative analysis of the microbicidal spectrum and expression patterns of different human beta-defensins.

    • Main Results:

    • Human beta-defensin-3 (HBD-3) demonstrates broad-spectrum activity against Gram-negative bacteria, Gram-positive bacteria (including multi-resistant strains), and fungi.
    • HBD-3 exhibits significant expression in non-epithelial tissues, unlike HBD-1 and HBD-2.
    • Human beta-defensin-4 (HBD-4) shows potent bactericidal activity against Pseudomonas aeruginosa and is expressed in epithelia and neutrophils.

    Conclusions:

    • Human beta-defensins, particularly HBD-3 and HBD-4, represent a vital component of the human antimicrobial defense system.
    • The distinct expression profiles and potent activities of HBD-3 and HBD-4 suggest specialized roles in combating microbial infections.
    • Further research into human antimicrobial peptides, especially their antifungal potential, is warranted for therapeutic applications.